Molecular signature for outcomes of triple negative breast cancer

Compared to other types of breast cancer, triple negative breast cancers are often more aggressive and have fewer treatment options. Researchers have identified a molecular mechanism that triple negative breast cancer cells use to survive and grow, and say that if this result is validated in clinical trials, certain women may be identified at high risk for recurrence early, and could be treated more aggressively.

Read the whole article on Science Daily

More from Science Daily